The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rubin, L. A.
Right arrow Articles by Nelson, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rubin, L. A.
Right arrow Articles by Nelson, D. L.

The Journal of Immunology, Vol 135, Issue 5 3172-3177, Copyright © 1985 by American Association of Immunologists

ARTICLES

Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro

LA Rubin, CC Kurman, ME Fritz, WE Biddison, B Boutin, R Yarchoan and DL Nelson

With the use of an enzyme-linked immunoabsorbent assay to measure soluble human interleukin 2 receptors (IL 2R), certain human T cell leukemia virus I (HTLV I)-positive T cell lines were found to spontaneously release large quantities of IL 2R into culture supernatants. This was not found with HTLV I-negative and IL 2 independent T cell lines, and only one of seven B cell-derived lines examined produced small amounts of IL 2R. In addition to this constitutive production of soluble IL 2R by certain cell lines, normal human peripheral blood mononuclear cells (PBMC) could be induced to release soluble IL 2R by plant lectins, the murine monoclonal antibody OKT3, tetanus toxoid, and allogeneic cells. Such activated cells also expressed cellular IL 2R measurable in detergent solubilized cell extracts. The generation of cellular and supernatant IL 2R was: dependent on cellular activation, rapid, radioresistant (3000 rad), and inhibited by cycloheximide treatment. NaDodSO4-polyacrylamide gel electrophoresis analysis of soluble IL 2R released from either the HTLV I-positive T cell line HUT 102B2 or normal phytohemagglutinin-activated PBMC demonstrated molecules of apparent Mr = 35,000 to 40,000, and 45,000 to 50,000, respectively, somewhat smaller than the mature surface receptor on these cells. The release of soluble IL 2R appears to be a characteristic marker of T lymphocyte activation and might serve an immunoregulatory function during both normal and abnormal cell growth and differentiation.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
L. M. Maier, D. E. Anderson, C. A. Severson, C. Baecher-Allan, B. Healy, D. V. Liu, K. D. Wittrup, P. L. De Jager, and D. A. Hafler
Soluble IL-2RA Levels in Multiple Sclerosis Subjects and the Effect of Soluble IL-2RA on Immune Responses
J. Immunol., February 1, 2009; 182(3): 1541 - 1547.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. S. von Bergwelt-Baildon, A. Popov, T. Saric, J. Chemnitz, S. Classen, M. S. Stoffel, F. Fiore, U. Roth, M. Beyer, S. Debey, et al.
CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition
Blood, July 1, 2006; 108(1): 228 - 237.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. J. Levine
Mechanisms of Soluble Cytokine Receptor Generation
J. Immunol., November 1, 2004; 173(9): 5343 - 5348.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. Moon, Y. Kim, M. Kim, J. Lim, C. S. Kang, W. I. Kim, S. I. Shim, N. G. Chung, Y. H. Park, W. S. Min, et al.
Plasma Soluble Interleukin-2 Receptor (sIL-2R) Levels in Patients with Acute Leukemia
Ann. Clin. Lab. Sci., October 1, 2004; 34(4): 410 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
D Y Chen, J L Lan, F J Lin, T Y Hsieh, and M C Wen
Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease
Ann Rheum Dis, October 1, 2004; 63(10): 1300 - 1306.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S.J. Fasouliotis, S.D. Spandorfer, S.S. Witkin, G. Schattman, H.C. Liu, J.E. Roberts, and Z. Rosenwaks
Maternal serum levels of interferon-{gamma} and interleukin-2 soluble receptor-{alpha} predict the outcome of early IVF pregnancies
Hum. Reprod., June 1, 2004; 19(6): 1357 - 1363.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. C. Grutters, J.-M. Fellrath, L. Mulder, R. Janssen, J. M. M. van den Bosch, and H. van Velzen-Blad
Serum Soluble Interleukin-2 Receptor Measurement in Patients With Sarcoidosis: A Clinical Evaluation
Chest, July 1, 2003; 124(1): 186 - 195.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
E. Moretti, B. Basso, L. Cervetta, A. Brigada, and G. Barbieri
Patterns of Cytokines and Soluble Cellular Receptors in the Sera of Children with Acute Chagas' Disease
Clin. Vaccine Immunol., November 1, 2002; 9(6): 1324 - 1327.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
E Maeshima, T Kobayashi, M Mune, and S Yukawa
Systemic lupus erythematosus with haemophagocytosis and severe liver disorder
Ann Rheum Dis, August 1, 2002; 61(8): 753 - 754.
[Full Text] [PDF]

Home page
 Br J OphthalmolHome page
M Huhtinen, H Repo, K Laasila, S-E Jansson, H Kautiainen, A Karma, and M Leirisalo-Repo
Systemic inflammation and innate immune response in patients with previous anterior uveitis
Br J Ophthalmol, April 1, 2002; 86(4): 412 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
O. Correia, L. Delgado, J.-C. Roujeau, L. Le Cleach, and J. A. Fleming-Torrinha
Soluble Interleukin 2 Receptor and Interleukin 1{alpha} in Toxic Epidermal Necrolysis: A Comparative Analysis of Serum and Blister Fluid Samples
Arch Dermatol, January 1, 2002; 138(1): 29 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L.-S. Wang, K.-C. Chow, W.-Y. Li, C.-C. Liu, Y.-C. Wu, and M.-H. Huang
Clinical Significance of Serum Soluble Interleukin 2 Receptor-{{alpha}} in Esophageal Squamous Cell Carcinoma
Clin. Cancer Res., April 1, 2000; 6(4): 1445 - 1451.
[Abstract] [Full Text]

Home page
 BloodHome page
F. Sayani, F. A. Montero-Julian, V. Ranchin, J. M. Prevost, S. Flavetta, W. Zhu, R. C. Woodman, H. Brailly, and C. B. Brown
Identification of the soluble granulocyte-macrophage colony stimulating factor receptor protein in vivo
Blood, January 15, 2000; 95(2): 461 - 469.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Iwasaki, K. Shimoda, S. Okamura, T. Otsuka, K. Nagafuji, N. Harada, Y. Ohno, T. Miyamoto, K. Akashi, M. Harada, et al.
Production of Soluble Granulocyte Colony-Stimulating Factor Receptors from Myelomonocytic Cells
J. Immunol., December 15, 1999; 163(12): 6907 - 6911.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
N. Aziz, P. Nishanian, R. Mitsuyasu, R. Detels, and J. L. Fahey
Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers
Clin. Vaccine Immunol., January 1, 1999; 6(1): 89 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
Y. Ohashi, Y. Nakai, A. Tanaka, Y. Kakinoki, Y. Washio, A. Kato, T. Masamoto, K. Yamada, and M. Hayashi
Serologic Study of the Working Mechanisms of Immunotherapy for Children With Perennial Allergic Rhinitis
Arch Otolaryngol Head Neck Surg, December 1, 1998; 124(12): 1337 - 1346.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Subtil, A. Rocca, and A. Dautry-Varsat
Molecular Characterization of the Signal Responsible for the Targeting of the Interleukin 2 Receptor beta  Chain toward Intracellular Degradation
J. Biol. Chem., November 6, 1998; 273(45): 29424 - 29429.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
N. Aziz, P. Nishanian, and J. L. Fahey
Levels of Cytokines and Immune Activation Markers in Plasma in Human Immunodeficiency Virus Infection: Quality Control Procedures
Clin. Vaccine Immunol., November 1, 1998; 5(6): 755 - 761.
[Abstract] [Full Text]

Home page
 JEMHome page
O. Schulz, H. F. Sewell, and F. Shakib
Proteolytic Cleavage of CD25, the {alpha} Subunit of the Human T Cell Interleukin 2 Receptor, by Der p 1, a Major Mite Allergen with Cysteine Protease Activity
J. Exp. Med., January 19, 1998; 187(2): 271 - 275.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
A. Subtil, M. Delepierre, and A. Dautry-Varsat
An {alpha}-Helical Signal in the Cytosolic Domain of the Interleukin 2 Receptor {beta} Chain Mediates Sorting Towards Degradation after Endocytosis
J. Cell Biol., February 10, 1997; 136(3): 583 - 595.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
M. Shaarawy, N. A. Darwish, and O. Abdel-Aziz
Serum Interleukin-2 and Soluble Interleukin-2 Receptor in Gestrational Trophoblastic Diseases
Reproductive Sciences, January 1, 1996; 3(1): 39 - 46.
[Abstract] [PDF]

Home page
 CirculationHome page
C. J. Limas, I. F. Goldenberg, and C. Limas
Soluble Interleukin-2 Receptor Levels in Patients With Dilated Cardiomyopathy : Correlation With Disease Severity and Cardiac Autoantibodies
Circulation, February 1, 1995; 91(3): 631 - 634.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
S.-C. Chang, Y.-T. Hsu, Y.-C. Chen, and C.-Y. Lin
Usefulness of Soluble Interleukin 2 Receptor in Differentiating Tuberculous and Carcinomatous Pleural Effusions
Arch Intern Med, May 23, 1994; 154(10): 1097 - 1101.
[Abstract] [PDF]

Home page
 J. Cell Sci.Home page
A Subtil, A Hemar, and A Dautry-Varsat
Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited
J. Cell Sci., January 12, 1994; 107(12): 3461 - 3468.
[Abstract] [PDF]

Home page
 ScienceHome page
D. Fischer, N Tal, D Novick, S Barak, and M Rubinstein
An antiviral soluble form of the LDL receptor induced by interferon
Science, October 8, 1993; 262(5131): 250 - 253.
[Abstract] [PDF]

Home page
 Arch DermatolHome page
B. D. Goldman, S.-K. Oh, B. E. Davis, M. E. Kadin, B. J. Poiesz, and H. K. Koh
Serum Soluble Interleukin 2 Receptor Levels in Erythrodermic Cutaneous T-Cell Lymphoma Correlate With Response to Photopheresis-Based Treatment
Arch Dermatol, September 1, 1993; 129(9): 1166 - 1170.
[Abstract] [PDF]

Home page
 LupusHome page
M.N. Manoussakis, G.S. Germanidis, A.A. Drosos, and H.M. Moutsopoulos
Impaired Urinary Excretion of Soluble IL-2 Receptors in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
Lupus, February 1, 1992; 1(2): 105 - 109.
[Abstract] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
M.-M. Hsu, J.-Y. Ko, and Y.-L. Chang
Elevated Levels of Soluble Interleukin 2 Receptor and Tumor Necrosis Factor in Nasopharyngeal Carcinoma
Arch Otolaryngol Head Neck Surg, November 1, 1991; 117(11): 1257 - 1259.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
L. A. Rubin and D. L. Nelson
The Soluble Interleukin-2 Receptor: Biology, Function, and Clinical Application
Ann Intern Med, October 15, 1990; 113(8): 619 - 627.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
R. Capra, F. Mattioli, N. Marciano', L. A. Vignolo, M. Bettinzioli, P. Airo', and R. Cattaneo
Significantly Higher Levels of Soluble Interleukin 2 in Patients With Relapsing-Remitting Multiple Sclerosis Compared With Healthy Subjects
Arch Neurol, March 1, 1990; 47(3): 254 - 254.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
R. A. Rudick and B. P. Barna
Serum Interleukin 2 and Soluble Interleukin 2 Receptor in Patients With Multiple Sclerosis Who Are Experiencing Severe Fatigue
Arch Neurol, March 1, 1990; 47(3): 254 - 255.
[Abstract] [PDF]

Home page
 JAMAHome page
B. J. Nickoloff, C. E. M. Griffiths, O. Baadsgaard, J. J. Voorhees, C. A. Hanson, and K. D. Cooper
Markedly Diminished Epidermal Keratinocyte Expression of Intercellular Adhesion Molecule-1 (ICAM-1) in Sezary Syndrome
JAMA, April 21, 1989; 261(15): 2217 - 2221.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
M. H. Rapaport, C. G. McAllister, D. Pickar, D. L. Nelson, and S. M. Paul
Elevated Levels of Soluble Interleukin 2 Receptors in Schizophrenia
Arch Gen Psychiatry, March 1, 1989; 46(3): 291 - 292.
[Abstract] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
R. Fernandez-Botran, V.M. Sanders, and E.S. Vitetta
Regulation of the Biological Effects of IL-4 on Murine T and B Cells
Cold Spring Harb Symp Quant Biol, January 1, 1989; 54(0): 705 - 711.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
L. Marcon, L. A. Rubin, C. C. Kurman, M. E. Fritz, D. L. Longo, T. Uchiyama, B. K. Edwards, and D. L. Nelson
Elevated Serum Levels of Soluble Tac Peptide in Adult T-Cell Leukemia: Correlation with Clinical Status during Chemotherapy
Ann Intern Med, August 15, 1988; 109(4): 274 - 279.
[Abstract] [PDF]

Home page
 Arch SurgHome page
M. T. Lotze, M. C. Custer, and S. A. Rosenberg
Intraperitoneal Administration of Interleukin-2 in Patients With Cancer
Arch Surg, December 1, 1986; 121(12): 1373 - 1379.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
W. C. GREENE, W. J. LEONARD, J. M. DEPPER, D. L. NELSON, and T. A. WALDMANN
The Human Interleukin-2 Receptor: Normal and Abnormal Expression in T Cells and in Leukemias Induced by the Human T-Lymphotropic Retroviruses
Ann Intern Med, October 1, 1986; 105(4): 560 - 572.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1985 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1985 by The American Association of Immunologists, Inc. All rights reserved.